Browsing Tag
Theranostics
5 posts
Curasight enters clinic with uTREAT for glioblastoma, advancing dual radiopharma strategy
Curasight starts first-in-human trial of uTREAT in glioblastoma, launching its therapeutic radiopharmaceutical program. Read the full strategic analysis.
Radiopharm Theranostics begins third-cohort enrolment in Phase 1 ¹⁷⁷Lu-RAD204 trial targeting PD-L1 tumours
Find out how Radiopharm Theranostics is advancing ¹⁷⁷Lu-RAD204 in PD-L1-positive tumours as it begins third-cohort enrolment in its Phase 1 trial.
Mirion Medical showcases advanced radiopharma safety and dosimetry systems at SNMMI 2025 in New Orleans
Mirion Medical unveils new radiation safety and workflow tools for radiopharma and theranostics at SNMMI 2025. Explore their latest innovations.
GE HealthCare unveils LesionID Pro and precision oncology suite to drive AI-led theranostics at SNMMI 2025
GE HealthCare launches LesionID Pro, Omni Legend, and MINItrace Magni at SNMMI 2025 to power AI-led theranostics and whole-body tumor imaging.
Mirion highlights full-spectrum nuclear medicine tools at SNMMI 2025 in New Orleans
Mirion Medical to showcase new dosimetry devices, radiopharmaceutical software, and safety tools at SNMMI 2025, reflecting broader sector convergence.